Skip to main content
. 2021 May 10;10(9):2032. doi: 10.3390/jcm10092032

Table 2.

Immunosuppression maintenance treatment and medication non-adherence assessed by the Morisky scale over time.

Follow-Up Visits
Immunosuppression Maintenance Treatment
M3 (N = 299) M6 (N = 298) M12 (N = 294) M24 (N = 286)
Tacrolimus, n (%) 227 (75.9) 228 (76.5) 225 (76.5) 216 (75.5)
Cyclosporine, n (%) 65 (21.7) 61 (20.5) 55 (18.7) 53 (18.5)
MMF, n (%) 283 (94.6) 266 (89.2) 263 (89.4) 251 (87.8)
Steroids, n (%) 255 (85.3) 203 (68.1) 166 (56.5) 142 (49.7)
CNI withdrawal, n (%) 7 (2.3) 9 (3.0) 14 (4.8) 17 (5.9)
Trough levels of tacrolimus, med (IQR) 8.8 (7.3–10.8) 8.2 (6.7–9.7) 7.6 (6.4–9.3) 7.5 (6.2–8.9)
Trough levels of cyclosporine, med (IQR) 156 (130–190) 149 (112–171) 128.5 (96–157) 93 (65–125)
Treatment Medication Non-Adherence Assessed by the Morisky Scale
M3 (N = 272) M6 (N = 263) M12 (N = 269) M24 (N = 234)
Positive response to questions of the Morisky scale, n (%)
Do you ever forget to take your medicine? 19 (7.0) 29 (10.9) 40 (14.9) 46 (19.5)
Are you careless at times about taking your medicine? 33 (12.1) 40 (15.2) 54 (20.1) 49 (20.8)
When you feel better, do you sometimes stop taking your medicine? 2 (0.7) 0 (0.0) 2 (0.7) 1 (0.4)
Sometimes if you feel worse when you take your medicine, do you stop taking it? 6 (2.2) 2 (0.7) 3 (1.1) 2 (0.8)
Non-adherent patients , n (%) 48 (17.6) 62 (23.6) 84 (31.2) 81 (34.6)
Always non-adherent patients , n (%) 12 (4.0)
Score of the Morisky scale, n (%)
4 224 (82.4) 201 (76.4) 185 (68.8) 153 (65.4)
3 41 (15.1) 54 (20.5) 72 (26.8) 66 (28.2)
≤2 7 (2.6) 8 (3.1) 12 (4.4) 15 (6.4)
Global score *, n (%)
16 96 (48.7)
15 42 (21.3)
13–14 42 (21.3)
≤12 17 (8.6)

M = month; N = subjects with available data; MMF = mycophenolate mofetil; med = median; IQR = interquartile range. subjects with at least one positive response at Morisky scale; subjects without missing data with a positive response at each visit; * sum of positive response(s) of every Morisky scale at each time point for patients without missing data.